| Psyclear, Llc | |
|
5055 West Park Boulevard Suite 400 Plano TX 75093 | |
| (972) 824-6577 | |
| Not Available |
| Full Name | Psyclear, Llc |
|---|---|
| Speciality | Psychologist |
| Location | 5055 West Park Boulevard, Plano, Texas |
| Authorized Official Name and Position | Michael P Giunta (CLINICAL DIRECTOR) |
| Authorized Official Contact | 9728246577 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Psyclear, Llc 5055 West Park Boulevard Suite 400 Plano TX 75093 Ph: (972) 824-6577 | Psyclear, Llc 5055 West Park Boulevard Suite 400 Plano TX 75093 Ph: (972) 824-6577 |
| NPI Number | 1003461468 |
|---|---|
| Provider Enumeration Date | 08/02/2019 |
| Last Update Date | 06/15/2020 |
| Certification Date | 06/15/2020 |
| Medicare PECOS PAC ID | 3779916085 |
|---|---|
| Medicare Enrollment ID | O20191127000520 |
News Archive
A study published in the September 2010 issue of SHOCK by Dr. Ed W. Childs and colleagues at Scott & White Healthcare looks at how female versus male rats fared after suffering a trauma and subsequent hemorrhagic shock who were given Estradiol (estrogen). In the study, the Estradiol prevented vascular permeability following hemorrhagic shock.
Research presented by P&G Beauty & Grooming scientists at the 68th Annual Meeting of the American Academy of Dermatology (Miami Beach, FL, March 5-9) examines skin care science from multiple perspectives, offering insights into how ingredient formulations, care regimens and gene expressions impact skin condition.
Capital Pro-Égaux Inc. (the "Company") (NEX: CPE.H) announces that its wholly owned subsidiary, Technique d'usinage Sinlab Inc. ("Sinlab"), has entered into a settlement agreement with Nobel Biocare AB; Nobel Biocare Italiana S.r.l.; Nobel Biocare Holding AG; Nobel Biocare Deutschland GmbH; Nobel Biocare Canada, Inc., a Canadian federal corporation; Biocad Médical Inc., a Quebec provincial corporation; Nobel Biocare USA, LLC, a Delaware limited liability company; and Nobel Biocare Procera, LLC, a Delaware limited liability company; (collectively "Nobel Entities") pursuant to which it settled civil actions in the United States, Canada, Italy and Germany involving the Nobel Entities and Sinblab.
The University of Massachusetts Medical School has licensed "anti-gal" technology developed by Professor of Surgery and Medicine Uri Galili, PhD, to newly formed biopharmaceutical company Agalimmune Ltd. for the purpose of developing innovative immunotherapies for the treatment of solid tumor cancers. Agalimmune is supported by an investment group comprising Loxbridge Research LLP and Animatrix Capital LLP and is based in London and California.
› Verified 4 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003461468 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | (* (Not Available)) | Primary |
| Provider Name | Michael P Giunta |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1528402575 PECOS PAC ID: 4688007990 Enrollment ID: I20191127000564 |
News Archive
A study published in the September 2010 issue of SHOCK by Dr. Ed W. Childs and colleagues at Scott & White Healthcare looks at how female versus male rats fared after suffering a trauma and subsequent hemorrhagic shock who were given Estradiol (estrogen). In the study, the Estradiol prevented vascular permeability following hemorrhagic shock.
Research presented by P&G Beauty & Grooming scientists at the 68th Annual Meeting of the American Academy of Dermatology (Miami Beach, FL, March 5-9) examines skin care science from multiple perspectives, offering insights into how ingredient formulations, care regimens and gene expressions impact skin condition.
Capital Pro-Égaux Inc. (the "Company") (NEX: CPE.H) announces that its wholly owned subsidiary, Technique d'usinage Sinlab Inc. ("Sinlab"), has entered into a settlement agreement with Nobel Biocare AB; Nobel Biocare Italiana S.r.l.; Nobel Biocare Holding AG; Nobel Biocare Deutschland GmbH; Nobel Biocare Canada, Inc., a Canadian federal corporation; Biocad Médical Inc., a Quebec provincial corporation; Nobel Biocare USA, LLC, a Delaware limited liability company; and Nobel Biocare Procera, LLC, a Delaware limited liability company; (collectively "Nobel Entities") pursuant to which it settled civil actions in the United States, Canada, Italy and Germany involving the Nobel Entities and Sinblab.
The University of Massachusetts Medical School has licensed "anti-gal" technology developed by Professor of Surgery and Medicine Uri Galili, PhD, to newly formed biopharmaceutical company Agalimmune Ltd. for the purpose of developing innovative immunotherapies for the treatment of solid tumor cancers. Agalimmune is supported by an investment group comprising Loxbridge Research LLP and Animatrix Capital LLP and is based in London and California.
› Verified 4 days ago
News Archive
A study published in the September 2010 issue of SHOCK by Dr. Ed W. Childs and colleagues at Scott & White Healthcare looks at how female versus male rats fared after suffering a trauma and subsequent hemorrhagic shock who were given Estradiol (estrogen). In the study, the Estradiol prevented vascular permeability following hemorrhagic shock.
Research presented by P&G Beauty & Grooming scientists at the 68th Annual Meeting of the American Academy of Dermatology (Miami Beach, FL, March 5-9) examines skin care science from multiple perspectives, offering insights into how ingredient formulations, care regimens and gene expressions impact skin condition.
Capital Pro-Égaux Inc. (the "Company") (NEX: CPE.H) announces that its wholly owned subsidiary, Technique d'usinage Sinlab Inc. ("Sinlab"), has entered into a settlement agreement with Nobel Biocare AB; Nobel Biocare Italiana S.r.l.; Nobel Biocare Holding AG; Nobel Biocare Deutschland GmbH; Nobel Biocare Canada, Inc., a Canadian federal corporation; Biocad Médical Inc., a Quebec provincial corporation; Nobel Biocare USA, LLC, a Delaware limited liability company; and Nobel Biocare Procera, LLC, a Delaware limited liability company; (collectively "Nobel Entities") pursuant to which it settled civil actions in the United States, Canada, Italy and Germany involving the Nobel Entities and Sinblab.
The University of Massachusetts Medical School has licensed "anti-gal" technology developed by Professor of Surgery and Medicine Uri Galili, PhD, to newly formed biopharmaceutical company Agalimmune Ltd. for the purpose of developing innovative immunotherapies for the treatment of solid tumor cancers. Agalimmune is supported by an investment group comprising Loxbridge Research LLP and Animatrix Capital LLP and is based in London and California.
› Verified 4 days ago
Tcn Pediatric Neurology, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4032 Mcdermott Rd, Suite 100, Plano, TX 75024 Phone: 972-469-9000 Fax: 972-769-0035 | |
Thomas Psychological Services Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6404 International Pkwy Ste 1010, Plano, TX 75093 Phone: 972-267-1988 Fax: 972-267-3434 | |
Autism Diagnostics Services Of Texas, P.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4040 Mcdermott Rd Ste 100, Plano, TX 75024 Phone: 855-295-3276 Fax: 888-588-2752 | |
Plano Neurology, Pa Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4601 Old Shepard Pl, #406, Plano, TX 75093 Phone: 972-867-3535 Fax: 972-867-3530 | |
Smart Neuro Health & Wellness Professionals Texas Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6839 Communications Pkwy, Plano, TX 75024 Phone: 469-225-0245 | |
Joel D Campbell, M.d., P.a. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 6124 W Parker Rd, Suite 432, Plano, TX 75093 Phone: 972-403-3100 Fax: 972-403-3105 |